홈8086 • TYO
add
니프로
전일 종가
¥1,417.00
일일 변동폭
¥1,414.00 - ¥1,426.50
52주 변동폭
¥1,070.50 - ¥1,480.00
시가총액
2433.87억 JPY
평균 거래량
69.66만
주가수익률
27.68
배당수익률
1.76%
기본 거래소
TYO
시장 뉴스
재무
손익계산서
수익
순이익
(JPY) | 2024년 6월info | 전년대비 변동 |
---|---|---|
수익 | 1523.92억 | 8.39% |
운영비 | 400.96억 | 12.23% |
순이익 | 26.26억 | -35.94% |
순이익률 | 1.72 | -41.10% |
주당 수익 | — | — |
EBITDA | 205.26억 | 5.13% |
유효 세율 | 50.72% | — |
대차대조표
총자산
총부채
(JPY) | 2024년 6월info | 전년대비 변동 |
---|---|---|
현금 및 단기 투자 | 835.99억 | -5.06% |
총자산 | 1.14조 | 9.23% |
총부채 | 8522.62억 | 7.68% |
총자기자본 | 2844.35억 | — |
발행 주식 | 1.63억 | — |
주가순자산비율 | 0.94 | — |
총자산이익률 | 1.29% | — |
자본이익률 | 1.58% | — |
현금 흐름
순현금흐름
(JPY) | 2024년 6월info | 전년대비 변동 |
---|---|---|
순이익 | 26.26억 | -35.94% |
영업 현금 흐름 | — | — |
투자 현금 흐름 | — | — |
자금 조달 현금 흐름 | — | — |
순현금흐름 | — | — |
잉여 현금 흐름 | — | — |
정보
Nipro Corporation is a Japanese medical equipment manufacturing company. Founded in 1954, the company is headquartered in Osaka and is listed on the Tokyo Stock Exchange and the Osaka Securities Exchange.
As of 2013 the company has 58 subsidiaries in Japan, Asia, North and South America and Europe. February 2018, the Company enters the endoscope-related business by making Machida Corporation its subsidiary.
April 1, 2019, the ethical pharmaceutical sales division of subsidiary Nipro ES Pharma Corporation is integrated into our domestic business division, Pharmaceutical Sales Division.
April 1, 2023, the Company's head office will be relocated to a new building constructed on the Company's own land in Kento Innovation Park in Settsu City. The registered head office and the location of the manufacturing and sales office based on the Law Concerning Assurance of Quality, Efficacy and Safety of Pharmaceuticals, Medical Devices and Other Products are scheduled to be relocated in October of the same year. Wikipedia
설립
1954. 7. 8.
웹사이트
직원 수
38,117